Stegent Equity Advisors Inc. Purchases 2,579 Shares of Colgate-Palmolive (NYSE:CL)

Stegent Equity Advisors Inc. lifted its position in shares of Colgate-Palmolive (NYSE:CLFree Report) by 23.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 13,546 shares of the company’s stock after purchasing an additional 2,579 shares during the period. Stegent Equity Advisors Inc.’s holdings in Colgate-Palmolive were worth $1,231,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently made changes to their positions in the company. Centricity Wealth Management LLC bought a new position in Colgate-Palmolive during the 4th quarter worth $27,000. Union Bancaire Privee UBP SA bought a new position in Colgate-Palmolive during the 4th quarter worth $32,000. Hager Investment Management Services LLC bought a new position in Colgate-Palmolive during the 4th quarter worth $36,000. Reston Wealth Management LLC bought a new position in Colgate-Palmolive during the 3rd quarter worth $42,000. Finally, Roxbury Financial LLC bought a new position in Colgate-Palmolive during the 4th quarter worth $43,000. Institutional investors own 80.41% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have commented on the company. Wells Fargo & Company lowered their price objective on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research note on Tuesday, January 7th. Raymond James restated an “outperform” rating and set a $105.00 price objective (down previously from $110.00) on shares of Colgate-Palmolive in a research note on Monday, February 3rd. TD Cowen lowered their price objective on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research note on Wednesday, January 8th. Stifel Nicolaus reduced their target price on Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating on the stock in a report on Monday, February 3rd. Finally, UBS Group reduced their target price on Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating on the stock in a report on Monday, February 3rd. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat.com, Colgate-Palmolive presently has an average rating of “Hold” and a consensus target price of $101.16.

View Our Latest Stock Analysis on CL

Colgate-Palmolive Trading Down 2.3 %

NYSE CL opened at $90.17 on Thursday. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40. Colgate-Palmolive has a twelve month low of $85.32 and a twelve month high of $109.30. The company has a market cap of $73.18 billion, a price-to-earnings ratio of 25.62, a price-to-earnings-growth ratio of 4.20 and a beta of 0.44. The business’s fifty day moving average is $88.81 and its 200 day moving average is $95.62.

Colgate-Palmolive (NYSE:CLGet Free Report) last released its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter in the prior year, the business posted $0.87 EPS. As a group, sell-side analysts expect that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, February 14th. Investors of record on Tuesday, January 21st were given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 2.22%. The ex-dividend date of this dividend was Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio is currently 56.82%.

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Recommended Stories

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.